欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
FR/H/0146/002
药品名称
Norlevo 1.5 mg
活性成分
levonorgestrel 1.5 mg
剂型
Tablet
上市许可持有人
HRA Pharma
参考成员国 - 产品名称
France (FR)
互认成员国 - 产品名称
Denmark (DK)
Belgium (BE)
Netherlands (NL)
NorLevo 1,5 mg, tabletten
Luxembourg (LU)
Ireland (IE)
Austria (AT)
Vikela 1,5 mg - Tablette
Italy (IT)
Greece (GR)
Sweden (SE)
Finland (FI)
Slovenia (SI)
许可日期
2005/07/05
最近更新日期
2023/01/31
药物ATC编码
G03AD01 levonorgestrel
G03AD Emergency contraceptives
G03A HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
申请类型
TypeLevel1：
Line Extension
TypeLevel2：
Additional Strength/Form
TypeLevel3：
Other [Article 10.1.(a)(iii), last paragraph]
TypeLevel4：
Chemical Substance
TypeLevel5：
Non Prescription (including OTC)
附件文件下载
Final Product Information
|
common-combined-norlevo-0-75-mg-annotated (RfSI 2 submi°)
Date of last change:2018/11/21
Final Product Information
|
common-combined-norlevo-0-75-mg-clean (RfSI 2 submi°)
Date of last change:2018/11/21
Final Product Information
|
common-combined-norlevo-1-5-mg-clean (RfSI 2 submi°)_2
Date of last change:2018/11/21
Final Product Information
|
common-combined-norlevo-0-75-mg-clean (RfSI 2 submi°)
Date of last change:2018/11/21
Final Product Information
|
common-combined-norlevo-1-5-mg-annotated (RfSI 2 submi°)
Date of last change:2018/11/21
Final Product Information
|
common-combined-norlevo-1-5-mg-clean (RfSI 2 submi°)
Date of last change:2018/11/21
PAR
|
Public Assessment Report NORLEVO
Date of last change:2013/12/24
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase